These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 9528862)

  • 41. Analysis of phosphotyrosine signaling in glioblastoma identifies STAT5 as a novel downstream target of ΔEGFR.
    Chumbalkar V; Latha K; Hwang Y; Maywald R; Hawley L; Sawaya R; Diao L; Baggerly K; Cavenee WK; Furnari FB; Bogler O
    J Proteome Res; 2011 Mar; 10(3):1343-52. PubMed ID: 21214269
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nuclear localization of p185neu tyrosine kinase and its association with transcriptional transactivation.
    Xie Y; Hung MC
    Biochem Biophys Res Commun; 1994 Sep; 203(3):1589-98. PubMed ID: 7945309
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Glycosylation-induced conformational modification positively regulates receptor-receptor association: a study with an aberrant epidermal growth factor receptor (EGFRvIII/DeltaEGFR) expressed in cancer cells.
    Fernandes H; Cohen S; Bishayee S
    J Biol Chem; 2001 Feb; 276(7):5375-83. PubMed ID: 11087732
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Soluble epidermal growth factor receptor acridinium-linked immunosorbent assay.
    Lafky JM; Baron AT; Maihle NJ
    Methods Mol Biol; 2006; 327():39-47. PubMed ID: 16780211
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Suppression of microRNA-9 by mutant EGFR signaling upregulates FOXP1 to enhance glioblastoma tumorigenicity.
    Gomez GG; Volinia S; Croce CM; Zanca C; Li M; Emnett R; Gutmann DH; Brennan CW; Furnari FB; Cavenee WK
    Cancer Res; 2014 Mar; 74(5):1429-39. PubMed ID: 24436148
    [TBL] [Abstract][Full Text] [Related]  

  • 46. EGFR targeted inhibition resistance: compensatory activation of ERBB family members in glioblastoma cancer stem-like cells promotes proliferation.
    Gursel DB; Schlaff CD; Boockvar JA
    Neurosurgery; 2012 Oct; 71(4):N17-8. PubMed ID: 22989968
    [No Abstract]   [Full Text] [Related]  

  • 47. Forced dimerization increases the activity of ΔEGFR/EGFRvIII and enhances its oncogenicity.
    Hwang Y; Chumbalkar V; Latha K; Bogler O
    Mol Cancer Res; 2011 Sep; 9(9):1199-208. PubMed ID: 21775422
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Biological studies and potential therapeutic applications of monoclonal antibodies and small molecules reactive with the neu/c-erbB-2 protein.
    Dougall WC; Greene MI
    Cell Biophys; 1994; 24-25():209-18. PubMed ID: 7736525
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Aberrant receptor signaling in human malignant gliomas: mechanisms and therapeutic implications.
    Nagane M; Lin H; Cavenee WK; Huang HJ
    Cancer Lett; 2001 Jan; 162 Suppl():S17-S21. PubMed ID: 11164186
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunologic approaches to inhibiting cell-surface-residing oncoproteins in human tumors.
    O'Rourke DM; Greene MI
    Immunol Res; 1998; 17(1-2):179-89. PubMed ID: 9479580
    [TBL] [Abstract][Full Text] [Related]  

  • 51. c-neu oncoprotein in developing rostral cerebral cortex: relationship to epidermal growth factor receptor.
    Kuhn PE; Miller MW
    J Comp Neurol; 1996 Aug; 372(2):189-203. PubMed ID: 8863125
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cell cycle-dependent regulation of p185neu: a relationship between disruption of this regulation and transformation.
    Kiyokawa N; Yan DH; Brown ME; Hung MC
    Proc Natl Acad Sci U S A; 1995 Feb; 92(4):1092-6. PubMed ID: 7862640
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Enhanced chemoresistance by elevation of p185neu levels in HER-2/neu-transfected human lung cancer cells.
    Tsai CM; Yu D; Chang KT; Wu LH; Perng RP; Ibrahim NK; Hung MC
    J Natl Cancer Inst; 1995 May; 87(9):682-4. PubMed ID: 7538595
    [No Abstract]   [Full Text] [Related]  

  • 54. Insulin receptor-like ectodomain genes and splice variants are found in both arthropods and human brain cDNA.
    Västermark Å; Rask-Andersen M; Sawant RS; Reiter JL; Schiöth HB; Williams MJ
    J Syst Evol; 2013 Nov; 51(6):664-670. PubMed ID: 27375681
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Helping EGFR inhibition to block cancer.
    Warta R; Herold-Mende C
    Nat Neurosci; 2017 Jul; 20(8):1035-1037. PubMed ID: 28745721
    [No Abstract]   [Full Text] [Related]  

  • 56. Correction to "Inhibition of phosphatidylinositol 3-kinase signaling negates the growth advantage imparted by a mutant epidermal growth factor receptor on human glioblastoma cells".
    Int J Cancer; 2024 Sep; 155(6):E7-E8. PubMed ID: 38861281
    [No Abstract]   [Full Text] [Related]  

  • 57. EGFRvIII Promotes Cell Survival during Endoplasmic Reticulum Stress through a Reticulocalbin 1-Dependent Mechanism.
    Gomez J; Areeb Z; Stuart SF; Nguyen HPT; Paradiso L; Zulkifli A; Madan S; Rajagopal V; Montgomery MK; Gan HK; Scott AM; Jones J; Kaye AH; Morokoff AP; Luwor RB
    Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33801941
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reversion of the ErbB malignant phenotype and the DNA damage response.
    Runkle EA; Zhang H; Cai Z; Zhu Z; Karger BL; Wu SL; O'Rourke DM; Zhou Z; Wang Q; Greene MI
    Exp Mol Pathol; 2012 Dec; 93(3):324-33. PubMed ID: 23022358
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The constitutive activity of epidermal growth factor receptor vIII leads to activation and differential trafficking of wild-type epidermal growth factor receptor and erbB2.
    Zeineldin R; Ning Y; Hudson LG
    J Histochem Cytochem; 2010 Jun; 58(6):529-41. PubMed ID: 20159766
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Suppression of human prostate tumor growth by a unique prostate-specific monoclonal antibody F77 targeting a glycolipid marker.
    Zhang G; Zhang H; Wang Q; Lal P; Carroll AM; de la Llera-Moya M; Xu X; Greene MI
    Proc Natl Acad Sci U S A; 2010 Jan; 107(2):732-7. PubMed ID: 20080743
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.